Cowen Inc’s ANI Pharmaceuticals ANIP Stock Holding History

Cowen Inc’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-15,000	Closed	-$93K	–	263
2015 Q2	$93K	Buy	+15,000	New	+$893K	0.01%	416

Other funds holding ANIP

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cowen Inc's ANIP Position: Q3 2015 in Review

Cowen Inc sold out of ANI Pharmaceuticals (ANIP) in Q3 2015, closing a stake of 2,613 shares — an estimated $162K sold.

Cowen Inc first reported a position in ANIP in Q2 2015 and held it in 1 quarter. The position peaked at $162K in Q2 2015. 121 funds tracked by Wall St. Rank hold ANIP as of Q3 2015.

Cowen Inc reported no remaining ANI Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Cowen Inc sold 2,613 ANI Pharmaceuticals shares in Q3 2015, an estimated $162K.
Cowen Inc first reported a position in ANI Pharmaceuticals in Q2 2015 and held it in 1 quarter.
Cowen Inc's ANI Pharmaceuticals position peaked at $162K in Q2 2015.
121 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2015.

Based on Cowen Inc's 13F filing for Q3 2015, filed 13 Nov 2015.